Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors

This study has been completed.
Sponsor:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00020150
First received: July 11, 2001
Last updated: April 28, 2015
Last verified: August 2004